RxSight Inc (RXST)
51.25
+0.15
(+0.29%)
USD |
NASDAQ |
Nov 04, 16:00
51.26
+0.02
(+0.03%)
After-Hours: 20:00
RxSight Enterprise Value: 1.795B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.795B |
| October 31, 2024 | 1.777B |
| October 30, 2024 | 1.799B |
| October 29, 2024 | 1.837B |
| October 28, 2024 | 1.761B |
| October 25, 2024 | 1.766B |
| October 24, 2024 | 1.734B |
| October 23, 2024 | 1.692B |
| October 22, 2024 | 1.762B |
| October 21, 2024 | 1.771B |
| October 18, 2024 | 1.770B |
| October 17, 2024 | 1.752B |
| October 16, 2024 | 1.777B |
| October 15, 2024 | 1.735B |
| October 14, 2024 | 1.761B |
| October 11, 2024 | 1.759B |
| October 10, 2024 | 1.747B |
| October 09, 2024 | 1.725B |
| October 08, 2024 | 1.721B |
| October 07, 2024 | 1.681B |
| October 04, 2024 | 1.707B |
| October 03, 2024 | 1.666B |
| October 02, 2024 | 1.654B |
| October 01, 2024 | 1.638B |
| September 30, 2024 | 1.728B |
| Date | Value |
|---|---|
| September 27, 2024 | 1.693B |
| September 26, 2024 | 1.707B |
| September 25, 2024 | 1.708B |
| September 24, 2024 | 1.707B |
| September 23, 2024 | 1.813B |
| September 20, 2024 | 1.869B |
| September 19, 2024 | 1.893B |
| September 18, 2024 | 1.916B |
| September 17, 2024 | 1.995B |
| September 16, 2024 | 1.971B |
| September 13, 2024 | 1.948B |
| September 12, 2024 | 1.931B |
| September 11, 2024 | 1.931B |
| September 10, 2024 | 1.888B |
| September 09, 2024 | 1.892B |
| September 06, 2024 | 1.868B |
| September 05, 2024 | 1.890B |
| September 04, 2024 | 1.905B |
| September 03, 2024 | 1.877B |
| August 30, 2024 | 2.004B |
| August 29, 2024 | 1.968B |
| August 28, 2024 | 1.927B |
| August 27, 2024 | 2.011B |
| August 26, 2024 | 1.983B |
| August 23, 2024 | 2.007B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
125.91M
Minimum
Jan 07 2022
2.398B
Maximum
May 15 2024
808.28M
Average
455.07M
Median
Enterprise Value Benchmarks
| Tandem Diabetes Care Inc | 1.985B |
| Twist Bioscience Corp | 2.146B |
| Perspective Therapeutics Inc | 524.04M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.079M |
| Revenue (Quarterly) | 34.89M |
| Total Expenses (Quarterly) | 43.22M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 69.51% |
| Profit Margin (Quarterly) | -17.42% |
| Earnings Yield | -1.97% |
| Normalized Earnings Yield | -1.909 |